Actively Recruiting
A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
Led by Huashan Hospital · Updated on 2022-05-24
2000
Participants Needed
1
Research Sites
262 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study was designed to analyze the efficacy and safety of Paxlovid for the treatment of COVID-19.
CONDITIONS
Official Title
A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants who have a positive SARS-CoV-2 test result
- Participants who have one or more mild or moderate COVID-19 symptoms
You will not qualify if you...
- No specific exclusion criteria in this real world study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Huashan Hospital Affiliated to Fudan University
Shanghai, China
Actively Recruiting
Research Team
F
Feng Sun, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here